Terns Pharmaceuticals, Inc. (TERN)

Last Year

14-May-23 -- 13-May-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

6

0

5

+1

0

+2

0

+3

Two Year Chart

14-May-22 -- 13-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
25-Jan-24 7:17 PM View:	23-Jan-24 Grant 0	Vignola Mark J. Chief Financial Officer		Terns Pharmaceuticals, Inc. - TERN	1038% 7.66K to 87.15K	0	0	--	--	Show Txns Hide Txns

02-Jun-23 5:03 PM View:	31-May-23 Private Purchase $2.98K	Sundaram Senthil Vel Chief Executive Officer Director		Terns Pharmaceuticals, Inc. - TERN	28% 7.66K to 9.77K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 7:18 PM View:	23-Jan-24 Grant 0	Yoon Seokho Bryan COO and General Counsel		Terns Pharmaceuticals, Inc. - TERN	1038% 7.66K to 87.15K	0	0	--	--	Show Txns Hide Txns

03-Apr-24 8:47 PM View:	03-Apr-24 Sale (Planned) ($856.01K)	Vivo Opportunity, LLC 10% Owner		Terns Pharmaceuticals, Inc. - TERN	(6%) 6.66M to 6.24M	0	0	--	--	Show Txns Hide Txns

25-Jan-24 7:17 PM View:	23-Jan-24 Grant 0	Quirk Erin President, Head of R&D		Terns Pharmaceuticals, Inc. - TERN	100% 0 to 75.0K	0	0	--	--	Show Txns Hide Txns

25-Jan-24 7:18 PM View:	23-Jan-24 Grant 0	Quigley Jill M. Sr. Advisor & Strategy Officer Director		Terns Pharmaceuticals, Inc. - TERN	100% 0 to 30.0K	0	0	--	--	Show Txns Hide Txns